Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia (Q40171279)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 February 2007
edit
Language Label Description Also known as
English
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
scientific article published on 13 February 2007

    Statements

    Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia (English)
    0 references
    0 references
    0 references
    0 references
    Jelena V Jovanovic
    Katherine Waghorn
    Finella Brito-Babapulle
    Rüdiger Hehlmann
    Nicholas C P Cross
    Andreas Reiter
    David Grimwade

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit